Vaccine Microarray Patches

 

Category: Pharmaceutical

Exhibitor: WCC BIOMEDICAL CO., LTD.

Booth No: L332

 

Characteristic

 

The future of immunization isn't a shot in the arm. It's a patch on your skin.
Vaccines have saved more lives than nearly any other medical intervention in history — yet the way we deliver them has remained largely unchanged for decades. A needle. A vial. A trained professional. A cold storage chain stretching thousands of miles.

Vaccine Microarray Patches (MAPs) are here to rewrite that story.
Backed by some of the world's most influential health organizations — including GAVI, PATH, and the Bill & Melinda Gates Foundation — MAP technology represents a genuine paradigm shift in how the world thinks about immunization. WCC is at the forefront of this transformation, currently co-developing mRNA vaccine MAPs with international partners to bring next-generation vaccine delivery to life.

Here's why vaccine MAPs are set to change everything:
① Accessible Administration — Putting vaccines in everyone's reach
Traditional vaccination requires trained healthcare professionals, dedicated facilities, and coordinated scheduling. Vaccine MAPs are designed to be potentially self-administered or applied without specialized medical training, dramatically lowering the barrier to immunization — particularly in underserved communities, remote regions, and humanitarian response scenarios where healthcare infrastructure is limited or absent.
② Painless & Non-Invasive — Removing the fear factor
Needle phobia affects an estimated 25% of adults worldwide and is one of the leading reasons people delay or avoid vaccination altogether. Vaccine MAPs dissolve harmlessly into the skin's surface, delivering immunization without the pain, anxiety, or psychological barrier of a conventional injection — making vaccination a more accessible and positive experience for patients of all ages.
③ Cold Chain Independence — Bringing vaccines where they've never gone before
Conventional vaccines are extraordinarily temperature-sensitive. Maintaining a reliable cold chain from manufacturing facility to patient arm requires significant infrastructure, energy, and cost — and any break in that chain can render entire vaccine batches ineffective. Vaccine MAPs offer exceptional temperature stability, eliminating cold chain dependency and enabling deployment in tropical climates, disaster zones, and resource-limited settings where refrigeration cannot be guaranteed. The logistical and economic implications are profound.
④ Biodegradable & Environmentally Responsible — Healthcare that doesn't cost the planet
Vaccine MAPs are manufactured from biodegradable materials, meaning they break down naturally after use without generating hazardous medical waste. This stands in sharp contrast to conventional syringes and vials, which contribute significantly to the growing challenge of pharmaceutical waste management. Choosing MAP technology is not just a clinical decision — it's an environmental one.
⑤ Elimination of Needlestick Injuries — Protecting the people who protect us
Needlestick injuries remain a serious occupational hazard for healthcare workers globally, carrying risks of bloodborne pathogen transmission including HIV and hepatitis. Vaccine MAPs eliminate this risk entirely. No sharps. No disposal protocols. No exposure incidents. By removing needles from the equation, MAP technology creates a safer working environment for every healthcare professional involved in vaccine administration.
⑥ Dose Sparing — Achieving more with less
The skin's outermost layers are rich in immunologically active dendritic cells — the body's frontline sentinels. By delivering vaccines directly into this immunologically dense environment, vaccine MAPs can elicit a robust immune response with a significantly lower antigen dose compared to conventional intramuscular injection. This dose-sparing capability has enormous implications for vaccine supply equity, cost efficiency, and global rollout speed — particularly during outbreak response and pandemic preparedness scenarios.

Beyond the six advantages above, vaccine MAPs also offer the potential for combination delivery — multiple antigens in a single patch — and open the door to personalized immunization schedules that are easier to administer, track, and scale. As mRNA vaccine technology continues to evolve rapidly, the synergy between mRNA formulations and MAP delivery systems positions this platform as one of the most consequential innovations in modern public health.
WCC is proud to be part of this global effort. Whether you represent a government health agency, a pharmaceutical partner, a global health NGO, or an academic research institution — we'd love to explore how MAP technology can serve your mission.
Reach out to us. The future of vaccines is ready to meet you.

 

Other Products

 

• 

  WINMAPᵀᴹ

• 

  DS MAPs

• 

  WINMAP™ Mini

• 

  Power Patch

• 

  V Patch

 

 

 

Back